|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑 ; k! S' [5 g. h' G
7 R1 \0 [$ h& ]今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了
2 z* R! p! [/ h# z& I
' f2 ]) W. {( P7 k/ J头颈肿瘤BU入选ASCO 2025的研究/ R/ _; Q1 f, u+ A7 {3 A
Hot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.
5 `- I T8 B. Y. Q# P肿瘤内科-头颈肿瘤科姜愚团队$ q1 I6 W {/ C7 F+ L7 Q1 e5 w
7 x* h- R W) z4 _. r! J; A9 y/ yNeoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.. m% i l4 F5 k6 K* W
肿瘤内科-头颈肿瘤科刘磊团队 {4 V% n1 {$ P
v9 o6 k9 J7 T
A phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.3 E" ~ t, [, ^. b; t
肿瘤内科-头颈肿瘤科刘磊团队# ] x9 \4 H# F6 D8 ^/ k5 |! F# {
: X4 {7 N7 h6 J' N4 V0 V$ c; c
A phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.9 |6 V+ ^3 u& F1 K, B6 J# N
肿瘤内科-头颈肿瘤科刘磊团队
7 }8 N1 D1 g; S. r% F t* H$ ] o: c% |: w2 k2 }& k s# U
ribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.. F6 L* V+ u4 z8 k" R
肿瘤内科-头颈肿瘤科姜愚团队& o' o1 y! j. Y9 T& n
|
|
[复制链接]
发表于 2025-5-9 16:51:15
